{"count":221272,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1955","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1953","results":[{"created":"2020-01-31T09:38:28.192829+11:00","panel_name":"Autism","panel_id":51,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kmt5b has been classified as Green List (High Evidence).","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:38:22.932054+11:00","panel_name":"Autism","panel_id":51,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KMT5B were changed from  to Mental retardation, autosomal dominant 51, MIM#617788","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:37:49.052126+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.11","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KMT5B as ready","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:37:49.046402+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.11","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kmt5b has been classified as Green List (High Evidence).","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:37:43.863996+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.11","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: KMT5B were set to ","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:36:57.219667+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KMT5B were changed from  to Mental retardation, autosomal dominant 51, MIM#617788","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:36:36.267336+11:00","panel_name":"Autism","panel_id":51,"panel_version":"0.45","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: KMT5B were set to ","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:36:35.424969+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1054","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: IRF2BPL: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 30057031; Phenotypes: Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","entity_name":"IRF2BPL","entity_type":"gene"},{"created":"2020-01-31T09:36:03.918721+11:00","panel_name":"Autism","panel_id":51,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KMT5B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:35:21.968445+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KMT5B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:35:08.000227+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1054","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KMT5B as ready","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:35:07.992734+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1054","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kmt5b has been classified as Green List (High Evidence).","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:34:53.016417+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.12","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: DHCR7: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Smith-Lemli-Opitz syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DHCR7","entity_type":"gene"},{"created":"2020-01-31T09:34:42.270829+11:00","panel_name":"Overgrowth","panel_id":151,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: KMT5B: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Mental retardation, autosomal dominant 51, MIM#617788; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:32:52.124357+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1054","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KMT5B were changed from  to Mental retardation, autosomal dominant 51","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:32:35.539401+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1053","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: KMT5B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:31:48.491153+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GNAO1 as ready","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:31:48.484495+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gnao1 has been classified as Green List (High Evidence).","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:31:38.814671+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAO1 were changed from  to Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:31:09.193154+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GNAO1 were set to ","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:30:37.088681+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1795","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GNAO1 as ready","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:30:37.082392+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1795","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gnao1 has been classified as Green List (High Evidence).","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:30:22.579649+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1795","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAO1 were changed from Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements to Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:29:48.398347+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1794","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAO1 were changed from  to Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:29:34.760208+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: GNAO1 was changed from  to Other","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:29:00.040380+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.7","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GNAO1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:28:37.091728+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1793","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GNAO1 were set to ","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:28:26.664836+11:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GNAO1: Rating: GREEN; Mode of pathogenicity: Other; Publications: 28747448, 30682224; Phenotypes: Epileptic encephalopathy, early infantile, 17, Neurodevelopmental disorder with involuntary movements; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:28:03.019061+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1792","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: GNAO1 was changed from  to Other","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:27:28.523492+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1791","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GNAO1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:26:48.083010+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1052","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GNAO1 as ready","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:26:48.075684+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1052","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gnao1 has been classified as Green List (High Evidence).","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:26:37.289186+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1052","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAO1 were changed from  to Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:26:16.197684+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1051","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GNAO1 were set to ","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:25:46.870850+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1790","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GNAO1: Rating: GREEN; Mode of pathogenicity: Other; Publications: 28747448, 30682224; Phenotypes: Epileptic encephalopathy, early infantile, 17, Neurodevelopmental disorder with involuntary movements; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:24:32.144645+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1050","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: KMT5B: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Mental retardation, autosomal dominant 51; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown; Current diagnostic: yes","entity_name":"KMT5B","entity_type":"gene"},{"created":"2020-01-31T09:23:11.636746+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1050","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: LONP1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 31636596; Phenotypes: CODAS syndrome, Mitochondrial cytopathy; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LONP1","entity_type":"gene"},{"created":"2020-01-31T09:21:05.040874+11:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.19","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: ADAMTS10: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 18567016; Phenotypes: Weill-Marchesani syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ADAMTS10","entity_type":"gene"},{"created":"2020-01-31T09:20:48.456210+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1050","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: GNAO1 was changed from  to Other","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:20:22.306177+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1049","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GNAO1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:20:00.228629+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1048","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GNAO1: Rating: GREEN; Mode of pathogenicity: Other; Publications: 28747448, 30682224; Phenotypes: Epileptic encephalopathy, early infantile, 17, Neurodevelopmental disorder with involuntary movements; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:17:48.876008+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.557","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GNAO1 as ready","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:17:48.868059+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.557","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gnao1 has been classified as Green List (High Evidence).","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:17:26.573936+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.557","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GNAO1 were changed from  to Epileptic encephalopathy, early infantile, 17; Neurodevelopmental disorder with involuntary movements","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:17:09.144829+11:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.3","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: IARS: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 27426735; Phenotypes: Growth retardation, impaired intellectual development, hypotonia, and hepatopathy; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"IARS","entity_type":"gene"},{"created":"2020-01-31T09:16:47.689051+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.556","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GNAO1 were set to ","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:16:00.166121+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.555","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GNAO1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:15:24.688652+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.554","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GNAO1: Rating: GREEN; Mode of pathogenicity: None; Publications: 28747448, 30682224; Phenotypes: Epileptic encephalopathy, early infantile, 17, Neurodevelopmental disorder with involuntary movements; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GNAO1","entity_type":"gene"},{"created":"2020-01-31T09:14:49.105505+11:00","panel_name":"Lissencephaly and Band Heterotopia","panel_id":15,"panel_version":"0.17","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: TUBA1A: Rating: GREEN; Mode of pathogenicity: Other; Publications: PMID: 30517687, 20466733; Phenotypes: Lissencephaly 3; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TUBA1A","entity_type":"gene"},{"created":"2020-01-31T09:10:36.417810+11:00","panel_name":"Autism","panel_id":51,"panel_version":"0.43","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: SOX5: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 31578471; Phenotypes: Lamb-Shaffer syndrome; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","entity_name":"SOX5","entity_type":"gene"},{"created":"2020-01-31T09:07:06.609613+11:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.108","user_name":"Elena Savva","item_type":"entity","text":"reviewed gene: LZTR1: Rating: GREEN; Mode of pathogenicity: Other; Publications: PMID: 25795793, 29469822, 30368668, 30481304, 24362817; Phenotypes: Noonan syndrome 10, Noonan syndrome 2, {Schwannomatosis-2, susceptibility to}; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"LZTR1","entity_type":"gene"},{"created":"2020-01-30T22:15:51.482444+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1790","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CAD as ready","entity_name":"CAD","entity_type":"gene"},{"created":"2020-01-30T22:15:51.476925+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1790","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cad has been classified as Green List (High Evidence).","entity_name":"CAD","entity_type":"gene"},{"created":"2020-01-30T22:15:30.611930+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1790","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CAD as Green List (high evidence)","entity_name":"CAD","entity_type":"gene"},{"created":"2020-01-30T22:15:30.606418+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1790","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cad has been classified as Green List (High Evidence).","entity_name":"CAD","entity_type":"gene"},{"created":"2020-01-30T22:14:55.524730+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1789","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CAD was added\ngene: CAD was added to Intellectual disability syndromic and non-syndromic. Sources: Expert list\nMode of inheritance for gene: CAD was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: CAD were set to 25678555; 28007989; 30914295\nPhenotypes for gene: CAD were set to Epileptic encephalopathy, early infantile, 50, MIM# MIM 616457\nReview for gene: CAD was set to GREEN\ngene: CAD was marked as current diagnostic\nAdded comment: Four unrelated families (two with same variant and Roma background, likely founder). \nSources: Expert list","entity_name":"CAD","entity_type":"gene"},{"created":"2020-01-30T22:08:29.128323+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1048","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CACNG2 as ready","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:08:29.122192+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1048","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacng2 has been classified as Red List (Low Evidence).","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:05:03.494660+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1048","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CACNG2 were changed from  to Mental retardation, autosomal dominant 10, MIM#614256","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:04:28.673655+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1788","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CACNG2 as ready","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:04:28.667939+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1788","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacng2 has been classified as Red List (Low Evidence).","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:04:19.089731+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1788","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CACNG2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:01:04.337151+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1787","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CACNG2 were changed from  to Mental retardation, autosomal dominant 10, MIM#614256","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:00:29.573754+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1047","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CACNG2 were set to ","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:00:12.635199+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1046","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CACNG2 as Red List (low evidence)","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T22:00:12.629284+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1046","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacng2 has been classified as Red List (Low Evidence).","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T21:59:52.276805+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1045","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CACNG2: Rating: RED; Mode of pathogenicity: None; Publications: 21376300; Phenotypes: Mental retardation, autosomal dominant 10, MIM#614256; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T21:59:41.546049+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1786","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CACNG2 were set to ","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T21:58:20.241807+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1785","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CACNG2 as Red List (low evidence)","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T21:58:20.233638+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1785","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacng2 has been classified as Red List (Low Evidence).","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T21:57:45.196344+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1784","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CACNG2: Rating: RED; Mode of pathogenicity: None; Publications: 21376300; Phenotypes: Mental retardation, autosomal dominant 10, MIM#614256; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CACNG2","entity_type":"gene"},{"created":"2020-01-30T20:07:55.225316+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1784","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PPM1D as ready","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T20:07:55.217522+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1784","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ppm1d has been classified as Green List (High Evidence).","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:59:11.957439+11:00","panel_name":"Renal Hypertension and Disorders of Aldosterone Metabolism","panel_id":190,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"panel","text":"removed gene:STX16 from the panel","entity_name":null,"entity_type":null},{"created":"2020-01-30T18:38:22.587685+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1045","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PPM1D as ready","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:38:22.581592+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1045","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ppm1d has been classified as Green List (High Evidence).","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:38:04.969316+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1045","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PPM1D were changed from  to Jansen de Vries syndrome, MIM #617450","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:35:08.213773+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1044","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PPM1D were set to ","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:34:31.664032+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1043","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PPM1D was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:34:15.964434+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1784","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PPM1D were changed from  to Jansen de Vries syndrome (MIM #617450)","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:34:07.903364+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1042","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PPM1D: Rating: GREEN; Mode of pathogenicity: None; Publications: 28343630, 31916397, 30795918, 29758292; Phenotypes: Jansen de Vries syndrome, MIM #617450; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:32:01.902819+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1783","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PPM1D were set to ","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:30:58.075839+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.1782","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PPM1D was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"PPM1D","entity_type":"gene"},{"created":"2020-01-30T18:29:09.073659+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1042","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EGFR as ready","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:29:09.067534+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1042","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: egfr has been classified as Red List (Low Evidence).","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:28:58.431723+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1042","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EGFR were changed from  to Inflammatory skin and bowel disease, neonatal, 2; OMIM # 616069","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:28:37.268912+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1041","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EGFR were set to ","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:28:12.772039+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1040","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EGFR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:27:47.688985+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1039","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EGFR as Red List (low evidence)","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:27:47.683077+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1039","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: egfr has been classified as Red List (Low Evidence).","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T18:27:21.141816+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1038","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EGFR: Rating: RED; Mode of pathogenicity: None; Publications: 24691054; Phenotypes: Inflammatory skin and bowel disease, neonatal, 2, OMIM # 616069; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EGFR","entity_type":"gene"},{"created":"2020-01-30T16:54:18.920677+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1038","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CLCNKA as ready","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-30T16:54:18.914298+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1038","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: clcnka has been classified as Amber List (Moderate Evidence).","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-30T16:54:06.115820+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1038","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CLCNKA were set to ","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-30T16:51:08.805308+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1037","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CLCNKA were changed from  to Bartter syndrome, type 4b, digenic; OMIM #613090","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-30T16:50:37.279158+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1036","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC9A3R1 as ready","entity_name":"SLC9A3R1","entity_type":"gene"},{"created":"2020-01-30T16:50:37.272994+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1036","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc9a3r1 has been classified as Red List (Low Evidence).","entity_name":"SLC9A3R1","entity_type":"gene"},{"created":"2020-01-30T16:50:28.812052+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1036","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC9A3R1 were changed from  to Nephrolithiasis/osteoporosis, hypophosphatemic, 2, MIM# 612287","entity_name":"SLC9A3R1","entity_type":"gene"},{"created":"2020-01-30T16:49:38.968260+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1035","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CLCNKA was changed from Unknown to Other","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-30T16:46:36.695397+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.1034","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CLCNKA as Amber List (moderate evidence)","entity_name":"CLCNKA","entity_type":"gene"}]}